AiVita Biomedical's Series B Round

AiVita Biomedical raised a round of funding on June 11, 2018. Investors include SFC.

AiVita Biomedical is advancing commercial and clinical-stage programs utilizing curative and regenerative medicines. Built upon expertise in stem cell growth and directed, high- purity differentiation…

Articles about AiVita Biomedical's Series B Round: